Company Description:
Our US patented dual function botanical drug-Kanglaite Injection (KLT) has been on top of best selling antineoplastic agents in China with over 600,000 cases of lung, liver, breast, kidney, colon, pancreatic cancers. Phase I trial in USA, Phase II in Russia and Phase III in China have proven that KLT can directly kill cancer cells and enhance immune capacity, effectively control cancerous pain, improve QOL, PPT and MST in palliative treatment.
We are seeking overseas sole agent. Contact us! |
